Financial Performance - RCM Technologies reported revenue of $78.2 million for the thirteen weeks ended June 28, 2025, representing a 13.0% increase from $69.2 million for the same period in 2024 [2] - For the twenty-six weeks ended June 28, 2025, revenue was $162.6 million, an increase of 15.3% compared to $141.1 million for the same period in 2024 [3] - Gross profit for the current quarter was $22.3 million, an 11.4% increase from $20.0 million in the prior year [2] - The company achieved GAAP net income of $3.8 million, or $0.50 per diluted share, for the current quarter, compared to $3.8 million, or $0.47 per diluted share, for the same quarter last year [2] - Adjusted EBITDA for the current quarter was $8.1 million, up from $7.2 million in the comparable prior quarter [2] Segment Performance - Revenue from the Specialty Health Care segment was $42.8 million for the thirteen weeks ended June 28, 2025, compared to $36.9 million in the prior year [16] - Engineering segment revenue was $26.5 million for the current quarter, up from $22.5 million in the same quarter last year [16] - Data and Solutions segment revenue was $8.8 million for the current quarter, down from $9.7 million in the prior year [16] Operational Insights - The company experienced a gross profit margin of 28.5% for the current quarter, slightly down from 28.9% in the prior year [16] - Operating income for the thirteen weeks ended June 28, 2025, was $6.6 million, compared to $5.8 million for the same period in 2024 [13] - The company’s total assets increased to $135.6 million as of June 28, 2025, from $132.1 million at the end of the previous year [19] Management Commentary - Bradley Vizi, Executive Chairman, noted consistent growth across all segments, indicating resilience in the business model [4] - Kevin Miller, Chief Financial Officer, highlighted the momentum in the Engineering segment as a key driver for future growth [4]

Core Viewpoint - RCM Technologies, Inc. reported strong financial results for the thirteen weeks ended March 29, 2025, with significant increases in revenue, gross profit, and net income compared to the prior year, indicating robust operational performance and effective investment strategies [2][3]. Financial Performance - Revenue for the current quarter was $84.5 million, a 17.4% increase from $71.9 million in the comparable prior quarter [2]. - Gross profit reached $22.0 million, reflecting a 7.9% increase from $20.4 million in the prior quarter [2]. - GAAP net income was $4.2 million, or $0.54 per diluted share, compared to $4.0 million, or $0.48 per diluted share, in the prior quarter [2]. - Adjusted EBITDA (non-GAAP) was $7.8 million, up from $6.8 million in the comparable prior quarter [2]. Operational Highlights - The company generated $16.7 million in cash flow from operations and reduced net debt by $12.0 million while retiring shares [3]. - The internal business metrics are strengthening, and the company is positioned well due to a thoughtful investment strategy [3]. Segment Performance - Revenue breakdown for the current quarter included $43.3 million from Life Sciences, $32.1 million from Specialty Health Care, and $9.0 million from Data and Solutions [16]. - Gross profit margins varied by segment, with Life Sciences at 28.2%, Specialty Health Care at 19.2%, and Data Solutions at 39.7% [16]. Upcoming Events - A conference call is scheduled for May 8, 2025, to discuss the financial results in detail [4].